nodes	percent_of_prediction	percent_of_DWPC	metapath
Praziquantel—CYP2D6—breast cancer	0.151	0.538	CbGaD
Praziquantel—CYP3A4—breast cancer	0.129	0.462	CbGaD
Praziquantel—CYP1A2—Anastrozole—breast cancer	0.0308	0.0614	CbGbCtD
Praziquantel—CYP1A2—Toremifene—breast cancer	0.0282	0.0561	CbGbCtD
Praziquantel—CYP3A5—Lapatinib—breast cancer	0.0276	0.055	CbGbCtD
Praziquantel—CYP2C19—Lapatinib—breast cancer	0.0223	0.0444	CbGbCtD
Praziquantel—CYP3A4—Exemestane—breast cancer	0.0213	0.0424	CbGbCtD
Praziquantel—CYP2D6—Idarubicin—breast cancer	0.0192	0.0383	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.0184	0.0367	CbGbCtD
Praziquantel—CYP3A7—Tamoxifen—breast cancer	0.0184	0.0367	CbGbCtD
Praziquantel—CYP3A4—Letrozole—breast cancer	0.0181	0.0361	CbGbCtD
Praziquantel—CYP3A4—Anastrozole—breast cancer	0.0161	0.0321	CbGbCtD
Praziquantel—CYP3A4—Toremifene—breast cancer	0.0148	0.0294	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.0143	0.0286	CbGbCtD
Praziquantel—CYP3A7—Paclitaxel—breast cancer	0.0143	0.0286	CbGbCtD
Praziquantel—CYP3A7—Irinotecan—breast cancer	0.0142	0.0282	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.0142	0.0282	CbGbCtD
Praziquantel—CYP3A5—Tamoxifen—breast cancer	0.0138	0.0275	CbGbCtD
Praziquantel—CYP3A4—Fulvestrant—breast cancer	0.0137	0.0273	CbGbCtD
Praziquantel—CYP3A4—Thiotepa—breast cancer	0.0122	0.0244	CbGbCtD
Praziquantel—CYP3A4—Ixabepilone—breast cancer	0.0112	0.0223	CbGbCtD
Praziquantel—CYP2C19—Tamoxifen—breast cancer	0.0112	0.0222	CbGbCtD
Praziquantel—CYP3A4—Lapatinib—breast cancer	0.0108	0.0214	CbGbCtD
Praziquantel—CYP3A5—Paclitaxel—breast cancer	0.0108	0.0214	CbGbCtD
Praziquantel—CYP3A5—Irinotecan—breast cancer	0.0106	0.0211	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.0104	0.0207	CbGbCtD
Praziquantel—CYP3A7—Docetaxel—breast cancer	0.0104	0.0207	CbGbCtD
Praziquantel—CYP1A2—Tamoxifen—breast cancer	0.0103	0.0205	CbGbCtD
Praziquantel—CYP2D6—Vinorelbine—breast cancer	0.00939	0.0187	CbGbCtD
Praziquantel—CYP2D6—Tamoxifen—breast cancer	0.00848	0.0169	CbGbCtD
Praziquantel—CYP3A4—Raloxifene—breast cancer	0.00816	0.0163	CbGbCtD
Praziquantel—CYP3A5—Docetaxel—breast cancer	0.00778	0.0155	CbGbCtD
Praziquantel—CYP1A2—Fluorouracil—breast cancer	0.00758	0.0151	CbGbCtD
Praziquantel—CYP3A4—Vinorelbine—breast cancer	0.00597	0.0119	CbGbCtD
Praziquantel—CYP2D6—Vinblastine—breast cancer	0.00579	0.0115	CbGbCtD
Praziquantel—CYP3A4—Tamoxifen—breast cancer	0.00539	0.0107	CbGbCtD
Praziquantel—CYP3A4—Mitoxantrone—breast cancer	0.00526	0.0105	CbGbCtD
Praziquantel—CYP3A4—Paclitaxel—breast cancer	0.0042	0.00836	CbGbCtD
Praziquantel—CYP3A4—Irinotecan—breast cancer	0.00414	0.00825	CbGbCtD
Praziquantel—CYP3A4—Vinblastine—breast cancer	0.00368	0.00733	CbGbCtD
Praziquantel—CYP2D6—Doxorubicin—breast cancer	0.00356	0.00708	CbGbCtD
Praziquantel—CYP3A4—Docetaxel—breast cancer	0.00303	0.00604	CbGbCtD
Praziquantel—CYP3A4—Doxorubicin—breast cancer	0.00226	0.0045	CbGbCtD
Praziquantel—Palonosetron—CYP2D6—breast cancer	0.00151	0.538	CrCbGaD
Praziquantel—Palonosetron—CYP3A4—breast cancer	0.00129	0.462	CrCbGaD
Praziquantel—Fatigue—Gemcitabine—breast cancer	0.000133	0.00096	CcSEcCtD
Praziquantel—Decreased appetite—Fluorouracil—breast cancer	0.000132	0.000952	CcSEcCtD
Praziquantel—Asthenia—Thiotepa—breast cancer	0.000132	0.00095	CcSEcCtD
Praziquantel—Diarrhoea—Vinorelbine—breast cancer	0.000132	0.000948	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000131	0.000945	CcSEcCtD
Praziquantel—Nausea—Melphalan—breast cancer	0.000131	0.000942	CcSEcCtD
Praziquantel—Feeling abnormal—Irinotecan—breast cancer	0.000131	0.000942	CcSEcCtD
Praziquantel—Feeling abnormal—Mitoxantrone—breast cancer	0.000131	0.000942	CcSEcCtD
Praziquantel—Pruritus—Thiotepa—breast cancer	0.00013	0.000936	CcSEcCtD
Praziquantel—Gastrointestinal pain—Mitoxantrone—breast cancer	0.00013	0.000935	CcSEcCtD
Praziquantel—Gastrointestinal pain—Irinotecan—breast cancer	0.00013	0.000935	CcSEcCtD
Praziquantel—Eosinophilia—Epirubicin—breast cancer	0.000129	0.000928	CcSEcCtD
Praziquantel—Nausea—Goserelin—breast cancer	0.000128	0.000919	CcSEcCtD
Praziquantel—Feeling abnormal—Gemcitabine—breast cancer	0.000127	0.000918	CcSEcCtD
Praziquantel—Dizziness—Vinorelbine—breast cancer	0.000127	0.000917	CcSEcCtD
Praziquantel—Nervous system disorder—Paclitaxel—breast cancer	0.000127	0.000914	CcSEcCtD
Praziquantel—Urticaria—Mitoxantrone—breast cancer	0.000126	0.000908	CcSEcCtD
Praziquantel—Diarrhoea—Thiotepa—breast cancer	0.000126	0.000906	CcSEcCtD
Praziquantel—Skin disorder—Paclitaxel—breast cancer	0.000126	0.000906	CcSEcCtD
Praziquantel—Abdominal pain—Irinotecan—breast cancer	0.000125	0.000904	CcSEcCtD
Praziquantel—Body temperature increased—Irinotecan—breast cancer	0.000125	0.000904	CcSEcCtD
Praziquantel—Abdominal pain—Mitoxantrone—breast cancer	0.000125	0.000904	CcSEcCtD
Praziquantel—Body temperature increased—Mitoxantrone—breast cancer	0.000125	0.000904	CcSEcCtD
Praziquantel—Feeling abnormal—Fluorouracil—breast cancer	0.000125	0.000902	CcSEcCtD
Praziquantel—Drowsiness—Methotrexate—breast cancer	0.000124	0.000893	CcSEcCtD
Praziquantel—Anorexia—Paclitaxel—breast cancer	0.000123	0.000889	CcSEcCtD
Praziquantel—Vomiting—Vinorelbine—breast cancer	0.000122	0.000881	CcSEcCtD
Praziquantel—Body temperature increased—Gemcitabine—breast cancer	0.000122	0.00088	CcSEcCtD
Praziquantel—Dizziness—Thiotepa—breast cancer	0.000121	0.000875	CcSEcCtD
Praziquantel—Rash—Vinorelbine—breast cancer	0.000121	0.000874	CcSEcCtD
Praziquantel—Dermatitis—Vinorelbine—breast cancer	0.000121	0.000873	CcSEcCtD
Praziquantel—Ill-defined disorder—Capecitabine—breast cancer	0.000121	0.00087	CcSEcCtD
Praziquantel—Urticaria—Fluorouracil—breast cancer	0.000121	0.00087	CcSEcCtD
Praziquantel—Headache—Vinorelbine—breast cancer	0.00012	0.000868	CcSEcCtD
Praziquantel—Body temperature increased—Fluorouracil—breast cancer	0.00012	0.000865	CcSEcCtD
Praziquantel—Eosinophilia—Doxorubicin—breast cancer	0.000119	0.000859	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000118	0.000849	CcSEcCtD
Praziquantel—Malaise—Capecitabine—breast cancer	0.000117	0.000845	CcSEcCtD
Praziquantel—Vertigo—Capecitabine—breast cancer	0.000117	0.000842	CcSEcCtD
Praziquantel—Hypersensitivity—Mitoxantrone—breast cancer	0.000117	0.000842	CcSEcCtD
Praziquantel—Hypersensitivity—Irinotecan—breast cancer	0.000117	0.000842	CcSEcCtD
Praziquantel—Vomiting—Thiotepa—breast cancer	0.000117	0.000842	CcSEcCtD
Praziquantel—Convulsion—Docetaxel—breast cancer	0.000116	0.000839	CcSEcCtD
Praziquantel—Drowsiness—Epirubicin—breast cancer	0.000116	0.000836	CcSEcCtD
Praziquantel—Rash—Thiotepa—breast cancer	0.000116	0.000835	CcSEcCtD
Praziquantel—Dermatitis—Thiotepa—breast cancer	0.000116	0.000834	CcSEcCtD
Praziquantel—Headache—Thiotepa—breast cancer	0.000115	0.000829	CcSEcCtD
Praziquantel—Somnolence—Paclitaxel—breast cancer	0.000115	0.000829	CcSEcCtD
Praziquantel—Myalgia—Docetaxel—breast cancer	0.000114	0.000824	CcSEcCtD
Praziquantel—Nausea—Vinorelbine—breast cancer	0.000114	0.000823	CcSEcCtD
Praziquantel—Asthenia—Mitoxantrone—breast cancer	0.000114	0.00082	CcSEcCtD
Praziquantel—Asthenia—Irinotecan—breast cancer	0.000114	0.00082	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000114	0.000819	CcSEcCtD
Praziquantel—Decreased appetite—Paclitaxel—breast cancer	0.000112	0.00081	CcSEcCtD
Praziquantel—Hypersensitivity—Fluorouracil—breast cancer	0.000112	0.000807	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000112	0.000805	CcSEcCtD
Praziquantel—Fatigue—Paclitaxel—breast cancer	0.000112	0.000804	CcSEcCtD
Praziquantel—Asthenia—Gemcitabine—breast cancer	0.000111	0.000799	CcSEcCtD
Praziquantel—Myalgia—Capecitabine—breast cancer	0.000111	0.000798	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.00011	0.000793	CcSEcCtD
Praziquantel—Discomfort—Capecitabine—breast cancer	0.000109	0.000788	CcSEcCtD
Praziquantel—Pruritus—Gemcitabine—breast cancer	0.000109	0.000788	CcSEcCtD
Praziquantel—Nausea—Thiotepa—breast cancer	0.000109	0.000786	CcSEcCtD
Praziquantel—Diarrhoea—Irinotecan—breast cancer	0.000109	0.000782	CcSEcCtD
Praziquantel—Diarrhoea—Mitoxantrone—breast cancer	0.000109	0.000782	CcSEcCtD
Praziquantel—Nervous system disorder—Docetaxel—breast cancer	0.000108	0.000775	CcSEcCtD
Praziquantel—Pruritus—Fluorouracil—breast cancer	0.000107	0.000775	CcSEcCtD
Praziquantel—Drowsiness—Doxorubicin—breast cancer	0.000107	0.000773	CcSEcCtD
Praziquantel—Feeling abnormal—Paclitaxel—breast cancer	0.000107	0.000768	CcSEcCtD
Praziquantel—Skin disorder—Docetaxel—breast cancer	0.000107	0.000768	CcSEcCtD
Praziquantel—Bradycardia—Epirubicin—breast cancer	0.000106	0.000764	CcSEcCtD
Praziquantel—Gastrointestinal pain—Paclitaxel—breast cancer	0.000106	0.000762	CcSEcCtD
Praziquantel—Diarrhoea—Gemcitabine—breast cancer	0.000106	0.000762	CcSEcCtD
Praziquantel—Dizziness—Irinotecan—breast cancer	0.000105	0.000756	CcSEcCtD
Praziquantel—Anorexia—Docetaxel—breast cancer	0.000105	0.000753	CcSEcCtD
Praziquantel—Nervous system disorder—Capecitabine—breast cancer	0.000104	0.00075	CcSEcCtD
Praziquantel—Diarrhoea—Fluorouracil—breast cancer	0.000104	0.000749	CcSEcCtD
Praziquantel—Cardiac disorder—Methotrexate—breast cancer	0.000103	0.000744	CcSEcCtD
Praziquantel—Skin disorder—Capecitabine—breast cancer	0.000103	0.000743	CcSEcCtD
Praziquantel—Urticaria—Paclitaxel—breast cancer	0.000103	0.000741	CcSEcCtD
Praziquantel—Abdominal pain—Paclitaxel—breast cancer	0.000102	0.000737	CcSEcCtD
Praziquantel—Body temperature increased—Paclitaxel—breast cancer	0.000102	0.000737	CcSEcCtD
Praziquantel—Anorexia—Capecitabine—breast cancer	0.000101	0.000729	CcSEcCtD
Praziquantel—Vomiting—Mitoxantrone—breast cancer	0.000101	0.000727	CcSEcCtD
Praziquantel—Vomiting—Irinotecan—breast cancer	0.000101	0.000727	CcSEcCtD
Praziquantel—Immune system disorder—Methotrexate—breast cancer	0.0001	0.000724	CcSEcCtD
Praziquantel—Dizziness—Fluorouracil—breast cancer	0.0001	0.000724	CcSEcCtD
Praziquantel—Rash—Mitoxantrone—breast cancer	0.0001	0.000721	CcSEcCtD
Praziquantel—Rash—Irinotecan—breast cancer	0.0001	0.000721	CcSEcCtD
Praziquantel—Dermatitis—Mitoxantrone—breast cancer	9.99e-05	0.00072	CcSEcCtD
Praziquantel—Dermatitis—Irinotecan—breast cancer	9.99e-05	0.00072	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Docetaxel—breast cancer	9.99e-05	0.00072	CcSEcCtD
Praziquantel—Headache—Irinotecan—breast cancer	9.94e-05	0.000716	CcSEcCtD
Praziquantel—Headache—Mitoxantrone—breast cancer	9.94e-05	0.000716	CcSEcCtD
Praziquantel—Vomiting—Gemcitabine—breast cancer	9.82e-05	0.000708	CcSEcCtD
Praziquantel—Bradycardia—Doxorubicin—breast cancer	9.81e-05	0.000707	CcSEcCtD
Praziquantel—Somnolence—Docetaxel—breast cancer	9.75e-05	0.000702	CcSEcCtD
Praziquantel—Rash—Gemcitabine—breast cancer	9.74e-05	0.000702	CcSEcCtD
Praziquantel—Dermatitis—Gemcitabine—breast cancer	9.73e-05	0.000701	CcSEcCtD
Praziquantel—Headache—Gemcitabine—breast cancer	9.68e-05	0.000698	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Capecitabine—breast cancer	9.67e-05	0.000697	CcSEcCtD
Praziquantel—Cardiac disorder—Epirubicin—breast cancer	9.66e-05	0.000696	CcSEcCtD
Praziquantel—Vomiting—Fluorouracil—breast cancer	9.66e-05	0.000696	CcSEcCtD
Praziquantel—Rash—Fluorouracil—breast cancer	9.58e-05	0.00069	CcSEcCtD
Praziquantel—Dermatitis—Fluorouracil—breast cancer	9.57e-05	0.00069	CcSEcCtD
Praziquantel—Decreased appetite—Docetaxel—breast cancer	9.53e-05	0.000687	CcSEcCtD
Praziquantel—Hypersensitivity—Paclitaxel—breast cancer	9.53e-05	0.000687	CcSEcCtD
Praziquantel—Headache—Fluorouracil—breast cancer	9.52e-05	0.000686	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Docetaxel—breast cancer	9.47e-05	0.000682	CcSEcCtD
Praziquantel—Fatigue—Docetaxel—breast cancer	9.45e-05	0.000681	CcSEcCtD
Praziquantel—Nausea—Mitoxantrone—breast cancer	9.42e-05	0.000679	CcSEcCtD
Praziquantel—Nausea—Irinotecan—breast cancer	9.42e-05	0.000679	CcSEcCtD
Praziquantel—Immune system disorder—Epirubicin—breast cancer	9.4e-05	0.000678	CcSEcCtD
Praziquantel—Arrhythmia—Epirubicin—breast cancer	9.3e-05	0.00067	CcSEcCtD
Praziquantel—Asthenia—Paclitaxel—breast cancer	9.28e-05	0.000669	CcSEcCtD
Praziquantel—Decreased appetite—Capecitabine—breast cancer	9.23e-05	0.000665	CcSEcCtD
Praziquantel—Nausea—Gemcitabine—breast cancer	9.18e-05	0.000661	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Capecitabine—breast cancer	9.16e-05	0.00066	CcSEcCtD
Praziquantel—Fatigue—Capecitabine—breast cancer	9.15e-05	0.00066	CcSEcCtD
Praziquantel—Pruritus—Paclitaxel—breast cancer	9.15e-05	0.00066	CcSEcCtD
Praziquantel—Feeling abnormal—Docetaxel—breast cancer	9.04e-05	0.000651	CcSEcCtD
Praziquantel—Nausea—Fluorouracil—breast cancer	9.02e-05	0.00065	CcSEcCtD
Praziquantel—Ill-defined disorder—Methotrexate—breast cancer	8.98e-05	0.000647	CcSEcCtD
Praziquantel—Gastrointestinal pain—Docetaxel—breast cancer	8.97e-05	0.000646	CcSEcCtD
Praziquantel—Cardiac disorder—Doxorubicin—breast cancer	8.94e-05	0.000644	CcSEcCtD
Praziquantel—Diarrhoea—Paclitaxel—breast cancer	8.85e-05	0.000638	CcSEcCtD
Praziquantel—Feeling abnormal—Capecitabine—breast cancer	8.75e-05	0.00063	CcSEcCtD
Praziquantel—Malaise—Methotrexate—breast cancer	8.73e-05	0.000629	CcSEcCtD
Praziquantel—Immune system disorder—Doxorubicin—breast cancer	8.7e-05	0.000627	CcSEcCtD
Praziquantel—Vertigo—Methotrexate—breast cancer	8.7e-05	0.000627	CcSEcCtD
Praziquantel—Gastrointestinal pain—Capecitabine—breast cancer	8.68e-05	0.000626	CcSEcCtD
Praziquantel—Abdominal pain—Docetaxel—breast cancer	8.67e-05	0.000625	CcSEcCtD
Praziquantel—Body temperature increased—Docetaxel—breast cancer	8.67e-05	0.000625	CcSEcCtD
Praziquantel—Arrhythmia—Doxorubicin—breast cancer	8.6e-05	0.00062	CcSEcCtD
Praziquantel—Dizziness—Paclitaxel—breast cancer	8.55e-05	0.000616	CcSEcCtD
Praziquantel—Urticaria—Capecitabine—breast cancer	8.43e-05	0.000608	CcSEcCtD
Praziquantel—Ill-defined disorder—Epirubicin—breast cancer	8.41e-05	0.000606	CcSEcCtD
Praziquantel—Abdominal pain—Capecitabine—breast cancer	8.39e-05	0.000605	CcSEcCtD
Praziquantel—Body temperature increased—Capecitabine—breast cancer	8.39e-05	0.000605	CcSEcCtD
Praziquantel—Convulsion—Methotrexate—breast cancer	8.39e-05	0.000605	CcSEcCtD
Praziquantel—Myalgia—Methotrexate—breast cancer	8.24e-05	0.000594	CcSEcCtD
Praziquantel—Vomiting—Paclitaxel—breast cancer	8.22e-05	0.000593	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	8.19e-05	0.00059	CcSEcCtD
Praziquantel—Malaise—Epirubicin—breast cancer	8.17e-05	0.000589	CcSEcCtD
Praziquantel—Rash—Paclitaxel—breast cancer	8.16e-05	0.000588	CcSEcCtD
Praziquantel—Dermatitis—Paclitaxel—breast cancer	8.15e-05	0.000587	CcSEcCtD
Praziquantel—Discomfort—Methotrexate—breast cancer	8.14e-05	0.000587	CcSEcCtD
Praziquantel—Vertigo—Epirubicin—breast cancer	8.14e-05	0.000587	CcSEcCtD
Praziquantel—Headache—Paclitaxel—breast cancer	8.1e-05	0.000584	CcSEcCtD
Praziquantel—Hypersensitivity—Docetaxel—breast cancer	8.08e-05	0.000582	CcSEcCtD
Praziquantel—Asthenia—Docetaxel—breast cancer	7.87e-05	0.000567	CcSEcCtD
Praziquantel—Convulsion—Epirubicin—breast cancer	7.85e-05	0.000566	CcSEcCtD
Praziquantel—Hypersensitivity—Capecitabine—breast cancer	7.82e-05	0.000564	CcSEcCtD
Praziquantel—Ill-defined disorder—Doxorubicin—breast cancer	7.78e-05	0.000561	CcSEcCtD
Praziquantel—Pruritus—Docetaxel—breast cancer	7.76e-05	0.000559	CcSEcCtD
Praziquantel—Nervous system disorder—Methotrexate—breast cancer	7.75e-05	0.000559	CcSEcCtD
Praziquantel—Myalgia—Epirubicin—breast cancer	7.71e-05	0.000556	CcSEcCtD
Praziquantel—Nausea—Paclitaxel—breast cancer	7.68e-05	0.000554	CcSEcCtD
Praziquantel—Skin disorder—Methotrexate—breast cancer	7.68e-05	0.000553	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	7.66e-05	0.000552	CcSEcCtD
Praziquantel—Discomfort—Epirubicin—breast cancer	7.62e-05	0.000549	CcSEcCtD
Praziquantel—Asthenia—Capecitabine—breast cancer	7.62e-05	0.000549	CcSEcCtD
Praziquantel—Malaise—Doxorubicin—breast cancer	7.56e-05	0.000545	CcSEcCtD
Praziquantel—Vertigo—Doxorubicin—breast cancer	7.53e-05	0.000543	CcSEcCtD
Praziquantel—Anorexia—Methotrexate—breast cancer	7.53e-05	0.000543	CcSEcCtD
Praziquantel—Pruritus—Capecitabine—breast cancer	7.51e-05	0.000541	CcSEcCtD
Praziquantel—Diarrhoea—Docetaxel—breast cancer	7.5e-05	0.000541	CcSEcCtD
Praziquantel—Convulsion—Doxorubicin—breast cancer	7.26e-05	0.000524	CcSEcCtD
Praziquantel—Diarrhoea—Capecitabine—breast cancer	7.26e-05	0.000523	CcSEcCtD
Praziquantel—Nervous system disorder—Epirubicin—breast cancer	7.25e-05	0.000523	CcSEcCtD
Praziquantel—Dizziness—Docetaxel—breast cancer	7.25e-05	0.000523	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Methotrexate—breast cancer	7.2e-05	0.000519	CcSEcCtD
Praziquantel—Skin disorder—Epirubicin—breast cancer	7.18e-05	0.000518	CcSEcCtD
Praziquantel—Myalgia—Doxorubicin—breast cancer	7.14e-05	0.000514	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	7.09e-05	0.000511	CcSEcCtD
Praziquantel—Discomfort—Doxorubicin—breast cancer	7.05e-05	0.000508	CcSEcCtD
Praziquantel—Anorexia—Epirubicin—breast cancer	7.05e-05	0.000508	CcSEcCtD
Praziquantel—Somnolence—Methotrexate—breast cancer	7.03e-05	0.000506	CcSEcCtD
Praziquantel—Dizziness—Capecitabine—breast cancer	7.02e-05	0.000506	CcSEcCtD
Praziquantel—Vomiting—Docetaxel—breast cancer	6.97e-05	0.000502	CcSEcCtD
Praziquantel—Rash—Docetaxel—breast cancer	6.91e-05	0.000498	CcSEcCtD
Praziquantel—Dermatitis—Docetaxel—breast cancer	6.91e-05	0.000498	CcSEcCtD
Praziquantel—Decreased appetite—Methotrexate—breast cancer	6.87e-05	0.000495	CcSEcCtD
Praziquantel—Headache—Docetaxel—breast cancer	6.87e-05	0.000495	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Methotrexate—breast cancer	6.82e-05	0.000492	CcSEcCtD
Praziquantel—Fatigue—Methotrexate—breast cancer	6.81e-05	0.000491	CcSEcCtD
Praziquantel—Vomiting—Capecitabine—breast cancer	6.75e-05	0.000486	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Epirubicin—breast cancer	6.74e-05	0.000486	CcSEcCtD
Praziquantel—Nervous system disorder—Doxorubicin—breast cancer	6.71e-05	0.000484	CcSEcCtD
Praziquantel—Rash—Capecitabine—breast cancer	6.69e-05	0.000482	CcSEcCtD
Praziquantel—Dermatitis—Capecitabine—breast cancer	6.69e-05	0.000482	CcSEcCtD
Praziquantel—Headache—Capecitabine—breast cancer	6.65e-05	0.000479	CcSEcCtD
Praziquantel—Skin disorder—Doxorubicin—breast cancer	6.65e-05	0.000479	CcSEcCtD
Praziquantel—Somnolence—Epirubicin—breast cancer	6.57e-05	0.000474	CcSEcCtD
Praziquantel—Anorexia—Doxorubicin—breast cancer	6.52e-05	0.00047	CcSEcCtD
Praziquantel—Nausea—Docetaxel—breast cancer	6.51e-05	0.000469	CcSEcCtD
Praziquantel—Feeling abnormal—Methotrexate—breast cancer	6.51e-05	0.000469	CcSEcCtD
Praziquantel—Gastrointestinal pain—Methotrexate—breast cancer	6.46e-05	0.000466	CcSEcCtD
Praziquantel—Decreased appetite—Epirubicin—breast cancer	6.43e-05	0.000463	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Epirubicin—breast cancer	6.38e-05	0.00046	CcSEcCtD
Praziquantel—Fatigue—Epirubicin—breast cancer	6.38e-05	0.000459	CcSEcCtD
Praziquantel—Nausea—Capecitabine—breast cancer	6.31e-05	0.000454	CcSEcCtD
Praziquantel—Urticaria—Methotrexate—breast cancer	6.28e-05	0.000452	CcSEcCtD
Praziquantel—Body temperature increased—Methotrexate—breast cancer	6.25e-05	0.00045	CcSEcCtD
Praziquantel—Abdominal pain—Methotrexate—breast cancer	6.25e-05	0.00045	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Doxorubicin—breast cancer	6.23e-05	0.000449	CcSEcCtD
Praziquantel—Feeling abnormal—Epirubicin—breast cancer	6.09e-05	0.000439	CcSEcCtD
Praziquantel—Somnolence—Doxorubicin—breast cancer	6.08e-05	0.000438	CcSEcCtD
Praziquantel—Gastrointestinal pain—Epirubicin—breast cancer	6.05e-05	0.000436	CcSEcCtD
Praziquantel—Decreased appetite—Doxorubicin—breast cancer	5.95e-05	0.000429	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Doxorubicin—breast cancer	5.91e-05	0.000426	CcSEcCtD
Praziquantel—Fatigue—Doxorubicin—breast cancer	5.9e-05	0.000425	CcSEcCtD
Praziquantel—Urticaria—Epirubicin—breast cancer	5.88e-05	0.000423	CcSEcCtD
Praziquantel—Abdominal pain—Epirubicin—breast cancer	5.85e-05	0.000421	CcSEcCtD
Praziquantel—Body temperature increased—Epirubicin—breast cancer	5.85e-05	0.000421	CcSEcCtD
Praziquantel—Hypersensitivity—Methotrexate—breast cancer	5.82e-05	0.00042	CcSEcCtD
Praziquantel—Asthenia—Methotrexate—breast cancer	5.67e-05	0.000409	CcSEcCtD
Praziquantel—Feeling abnormal—Doxorubicin—breast cancer	5.64e-05	0.000406	CcSEcCtD
Praziquantel—Gastrointestinal pain—Doxorubicin—breast cancer	5.6e-05	0.000403	CcSEcCtD
Praziquantel—Pruritus—Methotrexate—breast cancer	5.59e-05	0.000403	CcSEcCtD
Praziquantel—Hypersensitivity—Epirubicin—breast cancer	5.45e-05	0.000393	CcSEcCtD
Praziquantel—Urticaria—Doxorubicin—breast cancer	5.44e-05	0.000392	CcSEcCtD
Praziquantel—Abdominal pain—Doxorubicin—breast cancer	5.41e-05	0.00039	CcSEcCtD
Praziquantel—Body temperature increased—Doxorubicin—breast cancer	5.41e-05	0.00039	CcSEcCtD
Praziquantel—Diarrhoea—Methotrexate—breast cancer	5.41e-05	0.00039	CcSEcCtD
Praziquantel—Asthenia—Epirubicin—breast cancer	5.31e-05	0.000382	CcSEcCtD
Praziquantel—Pruritus—Epirubicin—breast cancer	5.23e-05	0.000377	CcSEcCtD
Praziquantel—Dizziness—Methotrexate—breast cancer	5.23e-05	0.000377	CcSEcCtD
Praziquantel—Diarrhoea—Epirubicin—breast cancer	5.06e-05	0.000365	CcSEcCtD
Praziquantel—Hypersensitivity—Doxorubicin—breast cancer	5.04e-05	0.000363	CcSEcCtD
Praziquantel—Vomiting—Methotrexate—breast cancer	5.02e-05	0.000362	CcSEcCtD
Praziquantel—Rash—Methotrexate—breast cancer	4.98e-05	0.000359	CcSEcCtD
Praziquantel—Dermatitis—Methotrexate—breast cancer	4.98e-05	0.000359	CcSEcCtD
Praziquantel—Headache—Methotrexate—breast cancer	4.95e-05	0.000357	CcSEcCtD
Praziquantel—Asthenia—Doxorubicin—breast cancer	4.91e-05	0.000354	CcSEcCtD
Praziquantel—Dizziness—Epirubicin—breast cancer	4.89e-05	0.000352	CcSEcCtD
Praziquantel—Pruritus—Doxorubicin—breast cancer	4.84e-05	0.000349	CcSEcCtD
Praziquantel—Vomiting—Epirubicin—breast cancer	4.7e-05	0.000339	CcSEcCtD
Praziquantel—Nausea—Methotrexate—breast cancer	4.69e-05	0.000338	CcSEcCtD
Praziquantel—Diarrhoea—Doxorubicin—breast cancer	4.68e-05	0.000337	CcSEcCtD
Praziquantel—Rash—Epirubicin—breast cancer	4.66e-05	0.000336	CcSEcCtD
Praziquantel—Dermatitis—Epirubicin—breast cancer	4.66e-05	0.000336	CcSEcCtD
Praziquantel—Headache—Epirubicin—breast cancer	4.63e-05	0.000334	CcSEcCtD
Praziquantel—Dizziness—Doxorubicin—breast cancer	4.53e-05	0.000326	CcSEcCtD
Praziquantel—Nausea—Epirubicin—breast cancer	4.39e-05	0.000317	CcSEcCtD
Praziquantel—Vomiting—Doxorubicin—breast cancer	4.35e-05	0.000314	CcSEcCtD
Praziquantel—Rash—Doxorubicin—breast cancer	4.31e-05	0.000311	CcSEcCtD
Praziquantel—Dermatitis—Doxorubicin—breast cancer	4.31e-05	0.000311	CcSEcCtD
Praziquantel—Headache—Doxorubicin—breast cancer	4.29e-05	0.000309	CcSEcCtD
Praziquantel—Nausea—Doxorubicin—breast cancer	4.06e-05	0.000293	CcSEcCtD
Praziquantel—CYP3A5—Metabolism—CYP19A1—breast cancer	5.89e-06	7.68e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CPT1A—breast cancer	5.88e-06	7.67e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ABCG2—breast cancer	5.88e-06	7.67e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—MTR—breast cancer	5.88e-06	7.67e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—BRIP1—breast cancer	5.85e-06	7.63e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—HPSE—breast cancer	5.85e-06	7.63e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—LDHB—breast cancer	5.85e-06	7.63e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—HPGDS—breast cancer	5.77e-06	7.52e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CYP17A1—breast cancer	5.76e-06	7.51e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—HBA1—breast cancer	5.73e-06	7.47e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PTGS1—breast cancer	5.7e-06	7.43e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ENO1—breast cancer	5.7e-06	7.43e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	5.68e-06	7.4e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CAV1—breast cancer	5.65e-06	7.37e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	5.61e-06	7.31e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ACHE—breast cancer	5.59e-06	7.29e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GSTT1—breast cancer	5.59e-06	7.29e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CYP2D6—breast cancer	5.59e-06	7.29e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—HMMR—breast cancer	5.55e-06	7.23e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTA3—breast cancer	5.55e-06	7.23e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ABCC1—breast cancer	5.55e-06	7.23e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	5.53e-06	7.2e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—NCOA2—breast cancer	5.49e-06	7.15e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—COMT—breast cancer	5.48e-06	7.14e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GSTP1—breast cancer	5.45e-06	7.11e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—HMOX1—breast cancer	5.38e-06	7.01e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PPARGC1B—breast cancer	5.37e-06	7e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ITPR1—breast cancer	5.37e-06	7e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—MED12—breast cancer	5.36e-06	6.99e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—DPYD—breast cancer	5.36e-06	6.99e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—FASN—breast cancer	5.32e-06	6.94e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—BCHE—breast cancer	5.3e-06	6.91e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CYP17A1—breast cancer	5.3e-06	6.9e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ALDOA—breast cancer	5.28e-06	6.88e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ENO1—breast cancer	5.24e-06	6.83e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PTGS1—breast cancer	5.24e-06	6.83e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—SLC5A5—breast cancer	5.23e-06	6.82e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ABCB1—breast cancer	5.16e-06	6.73e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PIK3CG—breast cancer	5.15e-06	6.71e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—NCOA3—breast cancer	5.12e-06	6.68e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—SLC2A2—breast cancer	5.09e-06	6.63e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTA4—breast cancer	5.07e-06	6.61e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CA9—breast cancer	5.07e-06	6.61e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—TYMS—breast cancer	5.07e-06	6.61e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—NQO1—breast cancer	5.05e-06	6.59e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—SLC2A1—breast cancer	5.05e-06	6.59e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—NCOA2—breast cancer	5.05e-06	6.58e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	5.03e-06	6.56e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PLA2G4A—breast cancer	5.01e-06	6.53e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—NCOR1—breast cancer	5.01e-06	6.53e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GSTM1—breast cancer	5.01e-06	6.53e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CPT1A—breast cancer	4.98e-06	6.5e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—MTR—breast cancer	4.98e-06	6.5e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ABCG2—breast cancer	4.98e-06	6.5e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.95e-06	6.45e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTA2—breast cancer	4.94e-06	6.45e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GPX2—breast cancer	4.94e-06	6.45e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CYP3A4—breast cancer	4.93e-06	6.43e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.9e-06	6.39e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—FASN—breast cancer	4.89e-06	6.38e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—HPGDS—breast cancer	4.89e-06	6.37e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GPX4—breast cancer	4.88e-06	6.37e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—SULT1A1—breast cancer	4.88e-06	6.37e-05	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—AKT1—breast cancer	4.88e-06	6.36e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—BCHE—breast cancer	4.87e-06	6.35e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—HBA1—breast cancer	4.86e-06	6.33e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CYP1B1—breast cancer	4.85e-06	6.32e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—SLC5A5—breast cancer	4.81e-06	6.28e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GPX1—breast cancer	4.8e-06	6.26e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTA1—breast cancer	4.77e-06	6.22e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—IDH1—breast cancer	4.77e-06	6.22e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—HSP90AA1—breast cancer	4.75e-06	6.2e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CYP1A1—breast cancer	4.75e-06	6.19e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ACHE—breast cancer	4.74e-06	6.18e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GSTT1—breast cancer	4.74e-06	6.18e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—NAT2—breast cancer	4.72e-06	6.15e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ERCC2—breast cancer	4.71e-06	6.14e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—SLC2A1—breast cancer	4.65e-06	6.06e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—NQO1—breast cancer	4.65e-06	6.06e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—NCOA1—breast cancer	4.62e-06	6.03e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—STK11—breast cancer	4.56e-06	5.94e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CYP19A1—breast cancer	4.56e-06	5.94e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CYP3A4—breast cancer	4.53e-06	5.91e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PIK3CD—breast cancer	4.52e-06	5.9e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CYP17A1—breast cancer	4.49e-06	5.85e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—ALB—breast cancer	4.47e-06	5.82e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CYP1B1—breast cancer	4.46e-06	5.81e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ENO1—breast cancer	4.44e-06	5.79e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PTGS1—breast cancer	4.44e-06	5.79e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—MTHFR—breast cancer	4.43e-06	5.77e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.42e-06	5.77e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—HSP90AA1—breast cancer	4.37e-06	5.7e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.37e-06	5.69e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CYP2D6—breast cancer	4.35e-06	5.68e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.28e-06	5.58e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—NCOA2—breast cancer	4.27e-06	5.57e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—NOS3—breast cancer	4.27e-06	5.57e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—NCOA1—breast cancer	4.25e-06	5.54e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—COMT—breast cancer	4.24e-06	5.52e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GSTP1—breast cancer	4.22e-06	5.5e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CYP19A1—breast cancer	4.19e-06	5.46e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—STK11—breast cancer	4.19e-06	5.46e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—HMOX1—breast cancer	4.16e-06	5.42e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ITPR1—breast cancer	4.15e-06	5.41e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—FASN—breast cancer	4.15e-06	5.41e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—MED12—breast cancer	4.14e-06	5.39e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—DPYD—breast cancer	4.14e-06	5.39e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—BCHE—breast cancer	4.13e-06	5.38e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CAV1—breast cancer	4.08e-06	5.33e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—SLC5A5—breast cancer	4.08e-06	5.32e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ALDOA—breast cancer	4.07e-06	5.31e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ABCB1—breast cancer	3.99e-06	5.2e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—NCOA3—breast cancer	3.95e-06	5.15e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PIK3CB—breast cancer	3.94e-06	5.14e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—NQO1—breast cancer	3.94e-06	5.13e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—SLC2A1—breast cancer	3.94e-06	5.13e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—SLC2A2—breast cancer	3.92e-06	5.12e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—TYMS—breast cancer	3.92e-06	5.11e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PTGS2—breast cancer	3.91e-06	5.1e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—COMT—breast cancer	3.9e-06	5.08e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GSTP1—breast cancer	3.88e-06	5.06e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GSTM1—breast cancer	3.87e-06	5.05e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PLA2G4A—breast cancer	3.87e-06	5.05e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—NCOR1—breast cancer	3.87e-06	5.05e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.86e-06	5.03e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CPT1A—breast cancer	3.85e-06	5.01e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ABCG2—breast cancer	3.85e-06	5.01e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—MTR—breast cancer	3.85e-06	5.01e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CYP3A4—breast cancer	3.84e-06	5.01e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—HMOX1—breast cancer	3.82e-06	4.99e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.82e-06	4.98e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ITPR1—breast cancer	3.82e-06	4.97e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CYP1B1—breast cancer	3.78e-06	4.92e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—HPGDS—breast cancer	3.77e-06	4.92e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—HBA1—breast cancer	3.75e-06	4.89e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PIK3CG—breast cancer	3.72e-06	4.85e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GPX1—breast cancer	3.71e-06	4.84e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—HSP90AA1—breast cancer	3.7e-06	4.83e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CYP1A1—breast cancer	3.67e-06	4.79e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ABCB1—breast cancer	3.67e-06	4.79e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTT1—breast cancer	3.66e-06	4.77e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ACHE—breast cancer	3.66e-06	4.77e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ERCC2—breast cancer	3.64e-06	4.75e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—TYMS—breast cancer	3.6e-06	4.7e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—NCOA1—breast cancer	3.6e-06	4.7e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GSTM1—breast cancer	3.56e-06	4.65e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PLA2G4A—breast cancer	3.56e-06	4.65e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—NCOR1—breast cancer	3.56e-06	4.65e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CYP19A1—breast cancer	3.55e-06	4.63e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—STK11—breast cancer	3.55e-06	4.63e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CYP17A1—breast cancer	3.46e-06	4.51e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ENO1—breast cancer	3.43e-06	4.47e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PTGS1—breast cancer	3.43e-06	4.47e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—MTHFR—breast cancer	3.42e-06	4.46e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GPX1—breast cancer	3.41e-06	4.45e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PTEN—breast cancer	3.41e-06	4.44e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CYP1A1—breast cancer	3.38e-06	4.4e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CYP2D6—breast cancer	3.36e-06	4.38e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ERCC2—breast cancer	3.35e-06	4.37e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.33e-06	4.34e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—COMT—breast cancer	3.3e-06	4.3e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—NCOA2—breast cancer	3.3e-06	4.3e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GSTP1—breast cancer	3.28e-06	4.28e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PIK3CD—breast cancer	3.27e-06	4.26e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—HMOX1—breast cancer	3.24e-06	4.22e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ITPR1—breast cancer	3.23e-06	4.21e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ALB—breast cancer	3.23e-06	4.21e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—FASN—breast cancer	3.2e-06	4.17e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—BCHE—breast cancer	3.19e-06	4.15e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CAV1—breast cancer	3.16e-06	4.12e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—MTHFR—breast cancer	3.15e-06	4.11e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—SLC5A5—breast cancer	3.15e-06	4.1e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ABCB1—breast cancer	3.11e-06	4.05e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—NOS3—breast cancer	3.09e-06	4.03e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—TYMS—breast cancer	3.05e-06	3.98e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—NQO1—breast cancer	3.04e-06	3.96e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—SLC2A1—breast cancer	3.04e-06	3.96e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—NCOR1—breast cancer	3.02e-06	3.94e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PLA2G4A—breast cancer	3.02e-06	3.94e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GSTM1—breast cancer	3.02e-06	3.94e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.02e-06	3.93e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CYP1B1—breast cancer	2.91e-06	3.8e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CAV1—breast cancer	2.9e-06	3.79e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GPX1—breast cancer	2.89e-06	3.77e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PIK3CG—breast cancer	2.88e-06	3.75e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CYP1A1—breast cancer	2.86e-06	3.73e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.86e-06	3.73e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PIK3CB—breast cancer	2.85e-06	3.72e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ERCC2—breast cancer	2.84e-06	3.7e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PTGS2—breast cancer	2.82e-06	3.68e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—NCOA1—breast cancer	2.78e-06	3.62e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—STK11—breast cancer	2.74e-06	3.57e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CYP19A1—breast cancer	2.74e-06	3.57e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—MTHFR—breast cancer	2.67e-06	3.48e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PIK3CG—breast cancer	2.65e-06	3.45e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—COMT—breast cancer	2.55e-06	3.32e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTP1—breast cancer	2.54e-06	3.31e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PIK3CD—breast cancer	2.53e-06	3.3e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—HMOX1—breast cancer	2.5e-06	3.26e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ALB—breast cancer	2.5e-06	3.25e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ITPR1—breast cancer	2.49e-06	3.25e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PTEN—breast cancer	2.46e-06	3.21e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CAV1—breast cancer	2.46e-06	3.21e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PIK3CA—breast cancer	2.4e-06	3.13e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ABCB1—breast cancer	2.4e-06	3.13e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—NOS3—breast cancer	2.39e-06	3.11e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—TYMS—breast cancer	2.36e-06	3.07e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.35e-06	3.07e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—NCOR1—breast cancer	2.33e-06	3.04e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.33e-06	3.04e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTM1—breast cancer	2.33e-06	3.04e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PIK3CD—breast cancer	2.33e-06	3.03e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ALB—breast cancer	2.3e-06	2.99e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PIK3CG—breast cancer	2.24e-06	2.92e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GPX1—breast cancer	2.23e-06	2.91e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CYP1A1—breast cancer	2.21e-06	2.88e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PIK3CB—breast cancer	2.2e-06	2.87e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—NOS3—breast cancer	2.2e-06	2.86e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ERCC2—breast cancer	2.19e-06	2.86e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PTGS2—breast cancer	2.18e-06	2.85e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—MTHFR—breast cancer	2.06e-06	2.68e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PIK3CB—breast cancer	2.03e-06	2.64e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PTGS2—breast cancer	2.01e-06	2.62e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PIK3CD—breast cancer	1.97e-06	2.57e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—AKT1—breast cancer	1.96e-06	2.56e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ALB—breast cancer	1.95e-06	2.54e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PTEN—breast cancer	1.9e-06	2.48e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CAV1—breast cancer	1.9e-06	2.48e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—NOS3—breast cancer	1.86e-06	2.43e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PTEN—breast cancer	1.75e-06	2.28e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PIK3CA—breast cancer	1.74e-06	2.27e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PIK3CG—breast cancer	1.73e-06	2.26e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PIK3CB—breast cancer	1.72e-06	2.24e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PTGS2—breast cancer	1.7e-06	2.22e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PIK3CD—breast cancer	1.52e-06	1.98e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ALB—breast cancer	1.5e-06	1.96e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PTEN—breast cancer	1.48e-06	1.93e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—NOS3—breast cancer	1.44e-06	1.87e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—AKT1—breast cancer	1.42e-06	1.85e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PIK3CA—breast cancer	1.34e-06	1.75e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PIK3CB—breast cancer	1.33e-06	1.73e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PTGS2—breast cancer	1.31e-06	1.71e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PIK3CA—breast cancer	1.24e-06	1.61e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PTEN—breast cancer	1.15e-06	1.49e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—AKT1—breast cancer	1.1e-06	1.43e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PIK3CA—breast cancer	1.05e-06	1.37e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—AKT1—breast cancer	1.01e-06	1.32e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—AKT1—breast cancer	8.55e-07	1.12e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PIK3CA—breast cancer	8.08e-07	1.05e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—AKT1—breast cancer	6.6e-07	8.61e-06	CbGpPWpGaD
